Page last updated: 2024-09-02

ecteinascidin 743 and Ascites

ecteinascidin 743 has been researched along with Ascites in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caratti, G; Colmegna, B; D'Incalci, M; Erba, E; Ferrari, M; Fruscio, R; Gobbi, M; Lorusso, D; Matteo, C; Mezzanzanica, D; Panini, N; Perlangeli, MV; Porcu, L; Raspagliesi, F; Romano, M; Zucchetti, M	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Ascites

Article	Year
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein. Biochemical pharmacology, 2017, 11-15, Volume: 144 Topics: Animals; Antineoplastic Agents, Alkylating; Ascites; Carbolines; Cell Line, Tumor; Dioxoles; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Nude; Orosomucoid; Ovarian Neoplasms; Protein Binding; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2017

Article

Year

Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein.

Biochemical pharmacology, 2017, 11-15, Volume: 144

Topics: Animals; Antineoplastic Agents, Alkylating; Ascites; Carbolines; Cell Line, Tumor; Dioxoles; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Nude; Orosomucoid; Ovarian Neoplasms; Protein Binding; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2017